Table 1. Main clinical characteristics... | American Society of Hematology

Table 1.

Main clinical characteristics of 32 patients with multiple myeloma

Patient no.	Sex	Age, y	HC	LC	Disease status	Stage	Lytic bone lesions
1	F	58		λ	D	IIIA	+
2	F	50		K	D	IIIA	+
3	F	51	G	λ	D	IA	+
4	M	70	A	λ	D	IIIA	+
5	F	82		λ	D	IIIB	+
6	M	82	G	λ	D	IIIA	+
7	F	65		λ	D	IIIA	+
8	F	53	G	K	D	IIIA	+
9	M	64	A	K	PR	IIA	+
10	F	72	G	K	PR	IA	+
11	M	74	G	K	PR	IIIA	+
12	F	62	A	λ	PR	IIIB	+
13	F	65	G	K	OR	IIIA	+
14	F	58	A	λ	Relapse	IIIA	+
15	F	74	G	K	Relapse	IIIA	+
16	F	62		K	NR-PD	IIIB	+
17	M	76	G	K	NR-PD	IIIA	+
18	M	74	G	K	NR-PD	IIIA	+
19	M	69	G	λ	NR-SD	IIIA	+
20	M	73	G	K	D	IA	-
21	F	74	G	K	Relapse	IIIA	-
22	F	55	G	K	D	IIA	-
23	M	55	G	K	Relapse	IIA	-
24	M	59	A	λ	D	IIA	-
25	M	71	A	K	D	IIA	-
26	M	63	G	K	Relapse	IIA	-
27	M	57	A	K	Relapse	IIA	-
28	F	66	G	λ	D	IIIA	+
29	M	62	G	K	Relapse	IIIA	+
30	M	73	G	λ	D	IIIA	+
31	F	75	G	K	D	IIIA	+
32	F	67	G	K	D	IIIA	+

Patient no.	Sex	Age, y	HC	LC	Disease status	Stage	Lytic bone lesions
1	F	58		λ	D	IIIA	+
2	F	50		K	D	IIIA	+
3	F	51	G	λ	D	IA	+
4	M	70	A	λ	D	IIIA	+
5	F	82		λ	D	IIIB	+
6	M	82	G	λ	D	IIIA	+
7	F	65		λ	D	IIIA	+
8	F	53	G	K	D	IIIA	+
9	M	64	A	K	PR	IIA	+
10	F	72	G	K	PR	IA	+
11	M	74	G	K	PR	IIIA	+
12	F	62	A	λ	PR	IIIB	+
13	F	65	G	K	OR	IIIA	+
14	F	58	A	λ	Relapse	IIIA	+
15	F	74	G	K	Relapse	IIIA	+
16	F	62		K	NR-PD	IIIB	+
17	M	76	G	K	NR-PD	IIIA	+
18	M	74	G	K	NR-PD	IIIA	+
19	M	69	G	λ	NR-SD	IIIA	+
20	M	73	G	K	D	IA	-
21	F	74	G	K	Relapse	IIIA	-
22	F	55	G	K	D	IIA	-
23	M	55	G	K	Relapse	IIA	-
24	M	59	A	λ	D	IIA	-
25	M	71	A	K	D	IIA	-
26	M	63	G	K	Relapse	IIA	-
27	M	57	A	K	Relapse	IIA	-
28	F	66	G	λ	D	IIIA	+
29	M	62	G	K	Relapse	IIIA	+
30	M	73	G	λ	D	IIIA	+
31	F	75	G	K	D	IIIA	+
32	F	67	G	K	D	IIIA	+

HC indicates heavy chain; LC, light chain; D, at diagnosis; PR, partial remission; OR, objective response; NR, no response; PD, progressive disease; SD, stable disease; + presence of lytic bone lesions; and -, absence of lytic bone lesions.

View Large

This Feature Is Available To Subscribers Only